药明康德 港股通 空最新增减持 (2026-07-21) 官网 ( 02359.hk) | 20.73 | 4.91 | 1.38% (1.35%) | 上市时间2018-12-13股价157.40港币涨跌幅-0.69%成交金额3.32亿港币换手率0.07%市值4,696.43亿港币H股市值803.49亿港币总股本29.84亿H股本5.10亿每手股数100上市至今年化投资收益率26.70%港股通持仓占H股比例12.25% (97.99亿港币2026-07-22) 累计做空占H股比例18.98% (148.21亿港币2026-07-17) | |||
| 所属三级行业生物技术 (恒生) | 市盈率 | 122.29 | 市净率 | 4.46 | 股息率 | 0.37% | 恒生:医疗保健业药品及生物科技生物技术 |
| 所属指数指数纳入纳出 | |||||||
| 同股同权 | 查看历史折扣 | ||||||
| 备注 (10): | 双击编辑备注 |
药明康德(02359) - 历史董事名单
| # | 姓名 | 职衔 | 职位 | 委任日期 | 辞任日期 |
|---|---|---|---|---|---|
| 1 | 盧韶華 | Independent Non Executive Director - A/F | 2023-05-31 | -- | |
| 2 | 俞衛 | Independent Non Executive Director | 2023-05-31 | -- | |
| 3 | 詹智玲 | Independent Non Executive Director | 2023-05-31 | -- | |
| 4 | 張新 | Independent Non Executive Director | 2023-05-31 | -- | |
| 5 | 陳民章 | Executive Director | CEO | 2022-05-06 | -- |
| 6 | 杨青 | Executive Director | CEO | 2020-05-15 | -- |
| 7 | 馮岱 | Independent Non Executive Director | 2018-08-22 | -- | |
| 8 | 蔡江南 | Independent Non Executive Director | 2017-03-17 | 2023-05-31 | |
| 9 | 劉艷 | Independent Non Executive Director | 2017-03-17 | 2023-05-31 | |
| 10 | 胡正國 | Executive Director | 2017-03-01 | -- | |
| 11 | 李革 | Executive Director | Chairman, CEO | 2017-03-01 | -- |
| 12 | 童小幪 | Non Executive Director | 2017-03-01 | -- | |
| 13 | 吳亦兵 | Non Executive Director | 2017-03-01 | -- | |
| 14 | 張朝暉 | Executive Director | 2017-03-01 | -- | |
| 15 | 婁賀統 | Independent Non Executive Director | 2017-03-01 | 2023-05-31 | |
| 16 | 張曉彤 | Independent Non Executive Director | 2017-03-01 | 2023-05-31 | |
| 17 | 趙寧 | Executive Director | 2017-03-01 | 2023-05-16 | |
| 18 | 劉曉鐘 | Executive Director | 2017-03-01 | 2020-03-24 |